心肌肌肉酸通道病变的生物物理机制
Anastasia K Zaytseva1,2, Olga E Kulichik3, Anna A Kostareva4
1Almazov National Medical Research Centre, St. Petersburg, Russia. zaytseva.anastasia.zak@gmail.com.
Pflugers Archiv : European journal of physiology
|February 29, 2024
概括
SCN5A基因中的遗传变异会导致心律失常,如LQT3 (功能增加) 和BrS1/PCCD (功能丧失),影响通道Na1.5功能和蛋白质相互作用.
科学领域:
- 心血管遗传学 心血管遗传学
- 分子心脏病学分子心脏病学
- 电子生理学 电子生理学
背景情况:
- SCN5A基因变异与诸如长QT综合征 (LQT3),布鲁加达综合征 (BrS1) 和渐进性心脏导电性疾病 (PCCD) 等心脏疾病有关.
- 了解这些SCN5A相关的通道病变的分子和生物物理机制已经取得了重大进展.
- 这些遗传变异可以改变Nav1.5通道功能,蛋白质相互作用和药物/环境敏感性.
研究的目的:
- 审查LQT3,BrS1和PCCD背后的生物物理机制.
- 突出目前研究模式的局限性,包括异质表达系统和诱导多能干细胞衍生心肌细胞.
- 总结目前对SCN5A突变的基因型-表型关系的理解.
主要方法:
- 对SCN5A基因变异和相关的心脏通道病变的文献综述.
- 对Nav1.5通道功能障碍的生物物理特性进行分析.
- 评估使用异质表达和iPSC衍生的心脏肌细胞的研究.
主要成果:
- LQT3与Na1.5功能的增益有关 (失效的无活化,增强的激活,迟到的电流).
- BrS1和PCCD与Nav1.5功能丧失 (减少电流,增强不活化,激活受损) 有关.
- SCN5A突变可以影响道相互作用,药物反应和pH/温度敏感性.
结论:
- SCN5A变异在Na1.5通道中引起明显的功能增益和丧失表型,导致特定的心律失常.
- 目前研究SCN5A突变的实验模型存在局限性.
- 需要进一步的研究,以充分阐明基因型-表型相关性,并改善患者管理.
相关概念视频
Mechanism of Cardiac Arrhythmias
919
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
919
Electrophysiology of Normal Cardiac Rhythm
4.2K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
4.2K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Voltage-gated Ion Channels
8.2K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
8.2K
Mechanically-gated Ion Channels
6.4K
Mechanically-gated ion channels are proteins found in eukaryotic and prokaryotic cell membranes that open in response to mechanical stress. Tension, compression, swelling, and shear stress can alter the conformation of the protein, opening a transmembrane channel that allows the passage of ions for signal transmission. In eukaryotes, mechanically-gated channels are distributed in several regions like the neurons, lungs, skin, bladder, and heart, where they play critical roles in numerous...
6.4K
Cardiac Action Potential
1.4K
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
1.4K


![Camera-based Measurements of Intracellular [Na+] in Murine Atrial Myocytes](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F59600.jpg&w=3840&q=50)